Advertisement
Wednesday, Sep 22, 2021
Outlook.com
Outlook.com

Covaxin Provides Protection Against Delta Plus Covid Variant: ICMR Study

Bharat Biotech’s Covaxin neutralises the Delta, Delta Plus (AY.1) and B.1.617.3 variants of SARS-CoV-2 effectively, the Indian Council of Medical and Research stated

Covaxin Provides Protection Against Delta Plus Covid Variant: ICMR Study
According to ICMR, Covaxin, has been found to provide 65.2 per cent protection against the Delta variant | PTI
Covaxin Provides Protection Against Delta Plus Covid Variant: ICMR Study
outlookindia.com
2021-08-03T07:35:54+05:30

Bharat Biotech’s COVID-19 vaccine, Covaxin, provides protection against Delta Plus (AY.1) variant of coronavirus, a new study conducted by the Indian Council of Medical and Research (ICMR) has stated.

In May, the World Health Organisation (WHO) tagged B.1.617.2 strain as the Delta variant of SARS-CoV-2. The variant was identified as one of the drivers of the second wave of coronavirus infections that devastated the country earlier this year. The Delta variant then, mutated to form the Delta Plus or AY.1 variant. The Delta Plus variant was first detected in India in April 2021 and subsequently reported in 20 other countries.

"ICMR study shows #Covaxin is effective in Delta, Delta AY.1 and B.1.617.3 variants," the apex health research body said in a tweet on Monday.

According to ICMR, Covaxin, has been found to provide “65.2 per cent protection against the Delta variant in a double-blind, randomized, multicentre, phase 3 clinical trial”. Covaxin is a whole-virion inactivated SARS-CoV-2 vaccine.

"Here, we have evaluated the IgG antibody titer and neutralizing potential of sera of COVID-19 naive individuals full doses of BBV152 vaccine, COVID-19 recovered cases with full dose vaccines and breakthrough cases post-immunization BBV152 vaccines against Delta, Delta AY.1 and B.1.617.3.," the study said.

"The results of the study reveal Covaxin neutralises the Delta, Delta AY.1 and B.1.617.3 variants effectively," the ICMR stated.

The study has been published on biorxiv, a pre-print server and has not been peer reviewed.

Covaxin demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the B.1.617.2 Delta variant, Bharat Biotech had said while concluding the final analysis of Covaxin efficacy from Phase-3 trials on July 3.

(With PTI inputs)

Advertisement

Outlook Newsletters

Advertisement

Read More from Outlook

UNGA: Joe Biden Says US Not Seeking 'New Cold War' With China

UNGA: Joe Biden Says US Not Seeking 'New Cold War' With China

Without mentioning China directly, Biden acknowledged increasing concerns about rising tensions, even as he has been out of sync with allies on the chaotic exit from Afghanistan.

Air Marshal VR Chaudhari Appointed New IAF Chief

Air Marshal VR Chaudhari Appointed New IAF Chief

Air Marshal V R Chaudhari will take the reins as the chief of the Indian Air Force after the incumbent, Air Chief Marshal RKS Bhadauria, retires on September 30.

Tyagi Snatches Thrilling IPL Win For RR As PBKS Commit Harakiri

Tyagi Snatches Thrilling IPL Win For RR As PBKS Commit Harakiri

With 3 needed off 4 balls in the final over, Kartik Tyagi took 2 wickets to help RR win by 2 runs.

Munna Bhais Still Flying High In High-Profile Entrance Examinations

Munna Bhais Still Flying High In High-Profile Entrance Examinations

Experts believe the swindlers have taken control of the entire system and they are doing so without any fear. They suspect one can get 99.5% only if one gets the question paper in advance.

Advertisement